COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Email Response from Gilles Gagnon on March 12, 2024

<< Previous

Bullboard Posts

Comment by Hopeforthebeston Nov 23, 2024 1:44pm

38 Views

Post# 36327489

RE:RE:RE:RE:RE:Email Response from Gilles Gagnon on March 12, 2024

Thank you BoazThorn appreciate another no woke person having his voice heard.People like Tropicalsun just do not get it but then he was probably one of the leads in the woke movement.

Anyway enjoy the sun, up here the weather is the $&iTs much like gagnon.

<< Previous

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages